1. |
- Sargeson, A. M., et al.
(author)
-
Names and symbols for the transfermium elements
- 1997
-
In: Pure and Applied Chemistry. - : Walter de Gruyter GmbH. - 0033-4545 .- 1365-3075. ; 69:12, s. 2471-2473
-
Journal article (peer-reviewed)abstract
- The recommendations (ref. 1) of the Commission on Nomenclature of Inorganic Chemistry (CNIC) on the nomenclature of the transfermium elements (101-109, inclusive) were considered by the IUPAC Bureau at Guildford (UK) in September 1995. As a result of the various criticisms of the recommendations and theway that they had been processed, the Bureau decided to adopt the recommendations as provisional and to circulate them to national/regional nomenclature centres in the normal way, with notices to be published innational/regional chemistry journals and magazines, requesting submission of comments to CNIC. In particular, the National Adhering Organizations (NAOs) were invited to express their views concerning the extant proposals for the names of these elements and the principles and traditions used to derive them. The response from the general chemical community was small, and the bulk of the replies came from nuclear scientists.
|
|
2. |
- Sargeson, A. M., et al.
(author)
-
Names and symbols of transfermium elements (IUPAC recommendations 1994)
- 1994
-
In: Pure and Applied Chemistry. - : Walter de Gruyter GmbH. - 0033-4545 .- 1365-3075. ; 66:12, s. 2419-2421
-
Journal article (peer-reviewed)abstract
- The Transfermium Working Group (TWG) was set up in 1986 under the joint auspices of the International Union of Pure and Applied Chemistry (IUPAC) and the International Union of Pure and Applied Physics (IUPAP). Its conclusions, duly endorsed by IUPAC and IUPAP, were published in the following three reports:1. Criteria that must be satisfied for the discovery of a new chemical element to be recognized, Pure & Appl. Chem., 63, 879-886 (1991).2. Discovery of the transfermium elements: Introduction to the discovery profiles, Pure & Appl. Chem., 65, 1757-1763 (1993).3, Discovery of the transfermium elements: Discovery profiles of the transfermium elements, Pure & Appl. Chem., 65, 1764-1814 (1993).IUPAC went a stage further by inviting responses on reports 2 and 3 from the three major groups concerned, i.e., Lawrence Berkeley Laboratory, California; Joint Institute for Nuclear Research, Dubna; and Gesellschaft fur Schwerionenforschung , Darmstadt. These responses together with the TWG's reply to the responses were published unedited in Pure & Appl. Chem.,Vol. 65, (1993), pp. 1815-1824.
|
|
3. |
- Batten, S. R., et al.
(author)
-
Coordination polymers, metal-organic frameworks and the need for terminology guidelines
- 2012
-
In: CrystEngComm. - : Royal Society of Chemistry (RSC). - 1466-8033. ; 14:9, s. 3001-3004
-
Journal article (peer-reviewed)abstract
- Coordination polymers (CPs) and metal–organic frameworks (MOFs) are among the most prolific research areas of inorganic chemistry and crystal engineering in the last 15 years, and yet it still seems that consensus is lacking about what they really are, or are not.
|
|
4. |
- Batten, S. R., et al.
(author)
-
Terminology of Metal-Organic Frameworks and Coordination Polymers (IUPAC recommendations 2013)
- 2013
-
In: Pure and Applied Chemistry. - 1365-3075 .- 0033-4545. ; 85:8, s. 1715-1724
-
Journal article (peer-reviewed)abstract
- A set of terms, definitions, and recommendations is provided for use in the classi- fication of coordination polymers, networks, and metal–organic frameworks (MOFs). A hier- archical terminology is recommended in which the most general term is coordination poly- mer. Coordination networks are a subset of coordination polymers and MOFs a further subset of coordination networks. One of the criteria an MOF needs to fulfill is that it contains poten- tial voids, but no physical measurements of porosity or other properties are demanded per se. The use of topology and topology descriptors to enhance the description of crystal structures of MOFs and 3D-coordination polymers is furthermore strongly recommended.
|
|
5. |
|
|
6. |
- Creutzig, Ursula, et al.
(author)
-
Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups.
- 2017
-
In: Pediatric blood & cancer. - : Wiley. - 1545-5017 .- 1545-5009. ; 64:12
-
Journal article (peer-reviewed)abstract
- There is no consensus on the treatment for pediatric patients with acute myeloid leukemia and initial central nervous system (CNS) involvement.To evaluate different CNS-directed treatment options (intrathecal [IT] therapy, CNS irradiation, hematopoietic stem cell transplantation [HSCT]), 261 patients (excluding acute promyelocytic leukemia) with initial CNS involvement treated in trials with similar intensive chemotherapy by four cooperative European study groups (1998-2013) were studied and compared with CNS-negative patients from the Berlin-Frankfurt-Münster group.Patient characteristics in the different study groups were comparable. Young age, high white blood cell count, extramedullary involvement other than the CNS, monoblastic morphology, and inv(16) were associated with CNS involvement (each P < 0.0001). There were no major differences in outcome between the study groups. The cumulative incidence of relapse (CIR) regarding the CNS was higher in initially CNS-positive versus initially CNS-negative patients (all: 8 ± 2% vs. 3 ± 1%, P(Gray) = 0.001; isolated: 4 ± 1% vs. 1 ± 0%, P(Gray) = 0.03). However, global outcome of the CNS-positive cohort (overall survival, 64 ± 3%; event-free survival 48 ± 3%; and CIR 33% ± 3%) did not differ significantly from CNS-negative patients. Risk groups defined by cytogenetics were of likewise prognostic significance in CNS-positive and -negative patients. CNS treatment with cranial irradiation was not superior compared to IT therapy and systemic chemotherapy (± HSCT).Although CNS relapses occurred more frequently in initially CNS-positive patients, their global outcome was similar as in CNS-negative patients. Intensified IT therapy was heterogeneous; however, at least eight applications, preferably with triple IT chemotherapy, seem to be appropriate to accompany dose-intensive systemic chemotherapy.
|
|
7. |
- Struik, A.F., et al.
(author)
-
Guanine-O6 Methylation Reduces the Reactivity of D(GpG) towards Platinum Complexes
- 1991
-
In: Journal of Inorganic Biochemistry. - 1873-3344. ; 44:4, s. 249-260
-
Journal article (peer-reviewed)abstract
- 06-methylated guanine dinucleotides were used to study the influence of hydrogen bonding on the specific binding of the antitumor drug cDDP, cis-PtCl2(NH3)2, to DNA. In this interaction, the guanine-06 site appears to be important in explaining the preference for a pGpG-N7(1),N7(2) chelate, which results from H-bridge formation with the ammine ligand of cDDP.Guanine-06 methylated dinucleotides and the nonmodified dinucleotides were reacted with [Pt(dien)Cl]+, cis-PtCl2(NH3)2, and cis-Pt(NH3)2(H2O)2]2+ and the reaction products were characterized by 1H NMR using pH titrations. Methylation at guanine-06 clearly reduces the preference for the guanine. In competition experiments monitored by NMR and experiments using UV spectrophotometry a decreasing reactivity towards [Pt(dien)(H2O)]2+ and cis-[Pt(NH3)2(H2O)2]2+ was found, in the order of d(GpG) > d(GomepG) > d(GomepGome) > d(GomepGome). The difference in reactivity between 5′ guanine methylation and 3′ guanine methylation is ascribed to differences in the H-bond formation with the backbone phosphate. The resulting reduced stacking of the bases in both modified dinucleotides, compared to the bases in d(GpG), results in a preference for the 3′ guanine over 5′.
|
|